Natco Pharma’s’ gets USFDA endorsement for Visakhapatnam plant Kumar Jeetendra | April 28, 2020 Natco Pharma today declared that it has gotten a last endorsement for its first supplemental condensed new medication application (ANDA) item from US Food and Drug Administration (USFDA) documented from its new medication plan office in JNPC SEZ, Ramky Pharma City, Visakhapatnam (Andhra Pradesh). ANDA, submitted as ‘earlier endorsement supplement’, accommodates NATCO’s Visakhapatnam office as …
